New scan could reveal cancer drug success in days, not months
NCT ID NCT04020978
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested a special PET scan method to see if it could detect early signs that targeted therapy is working for genitourinary cancer. Eleven patients had scans before and two weeks after starting treatment. The goal was to see if changes in tumor blood flow could predict later tumor shrinkage, potentially avoiding months of ineffective and costly treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Parametric PET/CT scan
What this could lead to
If successful, this could lead to a faster way to tell if a cancer treatment is working, saving patients from months of ineffective therapy.
What could go wrong
This is a very small pilot study with only 11 participants, so results may not apply broadly. The method is still experimental and needs much more testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UC Davis Medical Center
Sacramento, California, 95817, United States